semaglutide vs tirzepatide dosage chart and key differences, weight loss results (2026) Efficacy of tirzepatide 5, 10

The most common complaints were nausea (55% versus 12.6% with placebo), constipation (30.7% versus 11.6%), and vomiting (26.1% versus 4.1%)

The primary outcome is also a composite cardiovascular end point, and the aim is to show superiority over placebo

"NAION is a very serious and life-altering injury that can be caused by use of Ozempic or Wegovy." If you develop NAION while on this medication, it will likely result in permanent visual impairment, Gold said

[DOI] [PMC free article] [PubMed] [Google Scholar] [14].Zhan Q, Zhang J, Lin Y, et al

Our roots, our perspective, and our commitment to the people we serve are shaped by communities across the country

Learn more about our various services below, and do not hesitate to reach out with any questions